Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStomach cramping on Mounjaro is one of the most commonly reported side effects, particularly in the first weeks of treatment or after a dose increase. Tirzepatide slows how quickly food leaves the stomach, which changes the pressure and movement patterns in your gut — and that can produce cramps, bloating, or a dull ache that catches people off guard. For most people, these symptoms settle within days to a couple of weeks as the body adjusts. They are not usually a sign that something is seriously wrong, but there are specific patterns worth knowing so you can tell the difference between ordinary adjustment and something that needs prompt medical attention. These are prescription-only medicines, and a prescriber assesses your full picture before and during treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates two receptors, GIP and GLP-1, that are involved in regulating appetite and blood-sugar control. One of the downstream effects is a significant slowing of gastric emptying: food stays in the stomach and upper gut longer than it used to. That mechanical change is useful for weight management, because it prolongs the feeling of fullness. It also means your digestive system is working against a different pressure gradient, and muscle contractions in the stomach wall can intensify as it tries to push food through. The result, for many people, is a cramping sensation that arrives somewhere between an hour and three hours after eating.
The NHS medicines page for tirzepatide lists stomach pain, nausea, diarrhoea, constipation, and indigestion as common side effects, all of which share this root cause. Cramps specifically tend to feel like pressure or squeezing across the mid-abdomen, occasionally shifting lower. They are not the same as the severe radiating pain associated with pancreatitis, which is a different and much rarer concern covered below. Understanding the mechanism helps here: cramps caused by gastric-emptying changes generally improve as your body recalibrates, usually within one to two weeks of a new dose.
If you want more detail on how tirzepatide affects the digestive system broadly, the tirzepatide overview covers the mechanism alongside the clinical evidence.
There is a simple check worth doing before your next meal: run your eye over what you are about to eat and ask whether the portion is smaller than it was before treatment. Many people on Mounjaro underestimate how much their stomach's capacity has effectively changed, and eating the same volume as before is one of the fastest ways to trigger cramping.
Beyond portion size, a few evidence-consistent adjustments make a real difference during the adjustment window. Eating slowly (setting a timer for twenty minutes if you need a target) gives the stomach time to signal fullness before you overfill it. High-fat meals are a particular trigger because fat already slows gastric emptying; combining that with tirzepatide's own effect can produce significant cramping. Fizzy drinks add gas to an already pressurised environment. Spacing meals every three to four hours rather than grazing continuously gives the gut time to clear between loads.
Hydration matters too, especially if cramps are accompanied by looser stools. Sipping water steadily across the day rather than drinking large amounts at once tends to go down better. These adjustments are not a cure, but they consistently reduce how sharp and frequent the cramps are in those first weeks. Our detailed guide to a bad stomach on Mounjaro goes into each strategy in more depth, including what to do when symptoms persist past the two-week mark.
Most stomach cramping on Mounjaro resolves on its own. The symptoms that warrant same-day medical attention are distinct, and it is worth being clear about what they look like. Severe, persistent stomach pain that does not ease within a few hours (particularly if it spreads toward the back, or comes with repeated vomiting) should not be managed with paracetamol and patience. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines specifically highlighting acute pancreatitis: a serious but infrequent complication whose cardinal symptom is exactly that pattern of pain. The MHRA Yellow Card scheme is the place to report any suspected side effect, including worsening abdominal pain, and doing so contributes to the ongoing safety monitoring of these medicines.
Gallbladder-related pain is another distinct pattern: sharp pain in the upper right abdomen, sometimes moving toward the right shoulder, often after a fatty meal. This is separate from general cramping and also warrants prompt assessment. Dehydration from severe vomiting or diarrhoea is a third scenario where you should seek help rather than wait it out, as it can affect kidney function. For a fuller account of stomach pain patterns on tirzepatide and how to read them, this page on Mounjaro stomach pain covers each in detail.
If you are in the normal adjustment window but finding cramps noticeably worse after one dose than another, that pattern is worth mentioning at your next clinical review. At nume, a real prescriber reads your notes (not software) so concerns like this get picked up. The detailed breakdown of what causes stomach cramps on Mounjaro may also help you frame what you are experiencing before that conversation.
Cramps that are severe enough to disrupt daily life for more than two weeks, or that return sharply with each dose increase, are worth raising with your prescriber before the next scheduled review. In some cases, staying at the current dose for an extended period rather than titrating upward is the right call. Slowing the dose-increase schedule is a recognised clinical response and not a failure, the goal is the highest tolerated dose, not the fastest route to it.
It is also worth knowing that the private cost of treatment already factors in clinical support. A transparent treatment price that covers ongoing prescriber access means questions like these do not require a separate GP appointment or a new consultation fee. For context on how Mounjaro is priced privately and what a legitimate service includes, the information on getting Mounjaro through a regulated UK pharmacy is a useful reference. And if your Mounjaro symptoms are extending beyond the gut (some people also notice sleep disruption alongside gastrointestinal symptoms) that is worth mentioning too, as the two can compound each other.
The clinical team at nume
The clinical team profile explains how prescriber oversight works at each stage of treatment. If you are not yet on tirzepatide and are weighing it up, the weight-loss treatment overview sets out the full picture. When you are ready to talk things through, speaking to our prescribers is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.